Recent Finacing
Recent Raise
ChainGen Bio develops antibody‑conjugated small oligonucleotide conjugates (XOC) and operates a conjugation technology platform and standardized R&D labs targeting non‑hepatic delivery for rare diseases, oncology, and CNS.
Focus Areas
Recent Investors
Funding round
Investors